IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,402,937 | +96.8% | 479,368 | -2.7% | 0.00% | +100.0% |
| Q2 2023 | $9,349,554 | +46.7% | 492,860 | +19.9% | 0.00% | +100.0% |
| Q1 2023 | $6,375,339 | -14.1% | 411,047 | -1.6% | 0.00% | -50.0% |
| Q4 2022 | $7,418,488 | +279.9% | 417,943 | +19.5% | 0.00% | – |
| Q3 2022 | $1,953,000 | +40.1% | 349,875 | -2.1% | 0.00% | – |
| Q2 2022 | $1,394,000 | -31.4% | 357,241 | -3.1% | 0.00% | – |
| Q1 2022 | $2,031,000 | -38.8% | 368,486 | -5.4% | 0.00% | -100.0% |
| Q4 2021 | $3,319,000 | -2.4% | 389,396 | -0.4% | 0.00% | 0.0% |
| Q3 2021 | $3,399,000 | -22.9% | 391,045 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $4,410,000 | -38.9% | 417,310 | -7.2% | 0.00% | 0.0% |
| Q1 2021 | $7,213,000 | -66.6% | 449,651 | -3.7% | 0.00% | -75.0% |
| Q4 2020 | $21,564,000 | +42.8% | 466,838 | +8.8% | 0.00% | +33.3% |
| Q3 2020 | $15,098,000 | +126.9% | 429,031 | +57.0% | 0.00% | +50.0% |
| Q2 2020 | $6,655,000 | +1874.8% | 273,332 | +1163.6% | 0.00% | – |
| Q1 2020 | $337,000 | -9.9% | 21,631 | -8.2% | 0.00% | – |
| Q4 2019 | $374,000 | – | 23,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |